Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease.
Alexander V Sorokin, Christin G Hong, Angel M Aponte...
https://pubmed.ncbi.nlm.nih.gov/37698922Actively Recruiting
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-06-08
5000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying new methods of cardiac CT angiography that use lower doses of radiation to create images of the heart and blood vessels. This study aims to find out if these low-dose imaging techniques are accurate and if they can predict heart-related outcomes. It also monitors the progression of coronary artery disease and evaluates updated cardiac imaging software and artificial intelligence compared to standard imaging. Participants will undergo a CT scan of the heart and blood vessels using the Cannon Aquilion ONE CT system, which is designed to reduce radiation exposure. The scan may include a contrast agent to improve image quality and can last up to 2 hours. Additional imaging may be done based on initial results to assess disease progression or late events. Participants will be evaluated through physical exams, medical history, and blood tests to check kidney function. Follow-up may occur via phone or office visits to track any further cardiovascular testing or events. Researchers will compare cardiovascular events among participants with different levels of artery narrowing and assess the accuracy and quality of new imaging techniques. The study will continue until 2027 and includes safety monitoring and long-term outcome tracking.
CONDITIONS
Evaluating New Radiation Techniques for Cardiovascular Imaging
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day
Participants undergo coronary CT angiography using low-radiation dose CT technology to assess coronary artery disease and evaluate image quality with new CT techniques.
1 visit (in-person)
Duration - Up to several years
Participants are monitored over time to track cardiovascular events, progression of coronary plaques, and outcomes related to coronary artery disease.
Follow-up visits as requested by the ordering physician or as clinically indicated
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
M
Margaret C Lowery, R.N.
M
Marcus Y Chen, M.D.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Alexander V Sorokin, Christin G Hong, Angel M Aponte...
https://pubmed.ncbi.nlm.nih.gov/37698922Masaki Sato, Edward B Neufeld, Martin P Playford...
https://pubmed.ncbi.nlm.nih.gov/37471145Alexander V Sorokin, Nidhi Patel, Khaled M Abdelrahman...
https://pubmed.ncbi.nlm.nih.gov/35389891Andrew D Choi, Eric S Leifer, Jeannie Yu...
https://pubmed.ncbi.nlm.nih.gov/27591767